Graybug Vision, Inc. Employee Directory
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, focused on developing medicines for chronic diseases of the retina and optic nerve. It was founded in 2011 as a spin-out of the Wilmer Eye Institute at Johns Hopkins University School of Medicine. The company aims to improve management of vision-threatening eye diseases by delivering drugs into ocular tissue at a controlled rate for up to 12 months, potentially enhancing patient adherence and reducing healthcare burdens. Its development program targets conditions such as wet age-related macular degeneration and primary open-angle glaucoma. The company serves patients with chronic retinal and optic nerve diseases and the clinicians who treat them, emphasizing therapies designed to reduce treatment burden through extended dosing intervals. In 2023, a merger with CalciMedica closed, representing a notable corporate development in Graybug Vision's history.